Forbes February 2, 2021
Katie Jennings

The pharmaceutical industry has a paper problem. Every single box of medicine must include a paper insert with dosing instructions and technical information that can measure several feet long. Some patients read it over, some patients stash it in a drawer, while others just dump it in the trash. These pesky printouts can cause a massive headache for the entire drug supply chain if they are outdated or incorrect and result in a recall.

Novartis, one of the world’s largest pharmaceutical companies, thought it might have a solution: blockchain, the technology first popularized by bitcoin, which lets groups move value without the need for middlemen. Because blockchain requires networks moving value, the Basel, Switzerland-based company wasn’t prepared to go...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Blockchain, Pharma, Pharma / Biotech, Technology
Blockaid Raises $50 Million to Scale Support for Blockchain Security Platform
The Trump admin will encourage—not hinder—U.S. leadership in blockchain technology and cryptocurrency. We must seize the moment
Blockchain-Proven Content And Nvidia Alternative? Check Out CrowdGenAI
How New Tech Changes Blockchain: Web3 Trends 2025
Musk Reportedly Weighs Blockchain to Track Federal Spending

Share This Article